Novel melatonin-based treatments for major depression

The Lancet

Volumn 379, Issue 9812, 2012, Pages 216-

  Carroll, Bernard J ^a  

^a Pacific Behavioral Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; FLUOXETINE; MELATONIN DERIVATIVE; PD 6735; RAMELTEON; SERTRALINE; TASIMELTEON; UNCLASSIFIED DRUG; VENLAFAXINE; MELATONIN;

CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); DEPRESSION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; MAJOR DEPRESSION; NOTE;

DEPRESSIVE DISORDER, MAJOR; HUMANS; MELATONIN;

EID: 84856116151     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60096-8     Document Type: Letter

References (3)

1. IB Hickie, NL Rogers Novel melatonin-based therapies: potential advances in the treatment of major depression Lancet 378 2011 621 631
2. EH Turner, AM Matthews, E Linardatos, RA Tell, R Rosenthal Selective publication of antidepressant trials and its influence on apparent efficacy N Engl J Med 358 2008 252 260
3. R Horton The dawn of McScience New York Review of Books 2004 March 11. http://www.nybooks.com/articles/archives/2004/mar/11/the-dawn-of-mcscience/ (accessed Dec 16, 2011).